drug repurposing

Too affordable: how can we overcome the drug repurposing paradox?

Number 73-74

Drug Watch, Featured 12 September 2016 1

Looking for anticancer activity among off-patent drugs that are already approved to treat other conditions might seem a sensible way to speed up access to affordable new therapy options. Linda Geddes asks how such a [more]

Drug repurposing in oncology: patient and health systems opportunities

Number 72

Impact Factor 21 June 2016 1

Repurposing established drugs for oncology patients offers the potential to deliver cheaper and faster drug development. This could help close the widening gap between patient expectations and healthcare budgets, as the cost of medical anticancer [more]